Mankind Pharma Partners with Denovo Sciences for AI-Driven Drug Discovery Program
Mankind Pharma has partnered with Denovo Sciences to launch an AI-driven drug discovery program aimed at accelerating early-stage drug development. The collaboration focuses on reducing discovery timelines, improving lead candidate quality, and prioritizing molecules with strong development potential. Combining Mankind Pharma's research and clinical expertise with Denovo's AI platform, the partnership employs a human-in-the-loop model where AI-generated candidates are guided and validated by scientific experts to enhance precision and efficiency in drug discovery.